Latest Investment News

AdAlta Limited has been granted a key Canadian patent for its anti-fibrotic drug AD-214, completing its composition of matter protection across all major commercial markets. This milestone strengthens the company’s intellectual property portfolio and underpins its commercial strategy for AD-214.

Brightstar Resources has completed a $313 million funding package, fully financing its Goldfields Project to production and advancing the Sandstone Project towards a final investment decision.

Tivan Limited’s joint venture partners have approved the Feasibility Study for the Speewah Fluorite Project and committed a $5 million equity injection to advance development.

WCM Global Growth Limited has successfully completed a significant capital raising, issuing nearly 48.5 million new shares and securing $84.8 million through entitlement, shortfall offers, and a placement.

Atlantic Lithium secures a crucial green light from Ghana’s Parliament for its Ewoyaa Lithium Project, marking a key step towards production and investment decisions.

Atlas Arteria has announced an ordinary dividend of AUD 0.20 per security for the six months ending December 2025, payable in April 2026. The dividend is fully unfranked, reflecting foreign income components.

Premier Investments reported a modest 0.38% rise in net profit from continuing operations for the half-year ending January 2026, alongside a 3% increase in revenue and a fully franked interim dividend of 45 cents per share.

CLINUVEL Pharmaceuticals reports record first-half profits and confirms CEO Philippe Wolgen’s leadership through a pivotal growth phase, prioritising its vitiligo program and Nasdaq ambitions.

Neometals has confirmed primary copper sulphide mineralisation beneath the historic Rinaldi copper pit, with early assays revealing promising copper grades. The company is advancing geophysical surveys to better define the mineralised system.

S2 Resources and Black Raven Mining have signed a key Heritage Protection Agreement with the Wajarri Yamaji people, paving the way for exploration licences to be granted over the highly prospective Jillewarra Project in Western Australia.

Genesis Energy has successfully completed a NZ$300 million rights offer, with strong shareholder participation including the Crown maintaining its majority stake. The capital raise underpins the company’s Gen35 strategy and sets the stage for upcoming share trading.

Ramelius Resources has withdrawn forward-looking financial statements based on a high gold price assumption, issuing a revised investor presentation that reaffirms its strong production growth and shareholder return plans through to FY30.